[Skip to Content]
[Skip to Content Landing]
October 1995

The Use of Expanded Polytetrafluoroethylene (Gore-Tex) in Rhinoplasty: A 6-Year Experience

Author Affiliations

From the Department of Otolaryngology, Medical College of Virginia, Richmond (Dr Godin), and Hedgewood Surgical Center, New Orleans, La (Dr Johnson). Dr Waldman is in private practice, Lexington, Ky.

Arch Otolaryngol Head Neck Surg. 1995;121(10):1131-1136. doi:10.1001/archotol.1995.01890100043007

Objective:  To determine the safety and efficacy of expanded polytetrafluoroethylene (Gore-Tex soft-tissue patch, W. L. Gore & Assoc Inc, Flagstaff, Ariz) as an implant in rhinoplasty.

Design:  A retrospective study of 137 patients who underwent rhinoplasty including augmentation with Gore-Tex over a 6-year period. A review of the medical literature concerning the use of Gore-Tex as an implant in the head and neck was also conducted.

Setting:  Two major academic medical centers and two private office surgical centers.

Participants:  One hundred thirty-seven consecutive patients who received Gore-Tex implants in the course of rhinoplasty.

Intervention:  Sixty-nine patients presented for primary rhinoplasty; the remaining 68 presented for revision surgery. All received Gore-Tex nasal implants to augment the nasal dorsum and/or base. The grafts ranged from 1 to 6 mm in thickness. Follow-up ranged from 6 to 80 months, with an average of 25 months.

Outcome Measures:  Clinically noted complications and patient satisfaction.

Results:  Three (2.2%) of 137 grafts became infected and were removed. One graft was removed 5 months postoperatively because of excessive augmentation. None of the patients who underwent implant removal required subsequent augmentation. All 137 patients are pleased with their results.

Conclusion:  Gore-Tex is a safe and effective implant material to use in primary and revision rhinoplasty when augmentation is needed and autogenous material is not available or desirable.(Arch Otolaryngol Head Neck Surg. 1995;121:1131-1136)